NYSE:CRMD
CorMedix Inc Stock News
$5.12
-0.0800 (-1.54%)
At Close: May 17, 2024
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
01:55pm, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.Biogen Inc (NASDAQ: BIIB) was in the news for all wrong reasons, as an employee conferenc
The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review
12:00am, Sunday, 15'th Mar 2020
The biopharma space bled along with the rest of the market and COVID-19 levered biotechs weren't spared either.
Biogen Inc (NASDAQ: BIIB) was in the news for all wrong...
CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16
01:15pm, Friday, 06'th Mar 2020
BERKELEY HEIGHTS, N.J., March 06, 2020 -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for.
Earnings Preview: CorMedix (CRMD) Q4 Earnings Expected to Decline
12:00am, Thursday, 05'th Mar 2020Riversedge Advisors, Llc Buys iShares Edge MSCI Min Vol Global, iShares Core MSCI Emerging ...
12:00am, Friday, 14'th Feb 2020
So far Tuesday, February 4, NASDAQ is up 2.55% and the S&P is up 1.73%. Let’s take a look at
CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program
09:19pm, Monday, 03'rd Feb 2020
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,
CorMedix Approved To Sell $5.5M Of NOL Tax Benefits Through New Jersey Economic Development Authority Program
09:19pm, Monday, 03'rd Feb 2020CorMedix Inc. Announces FDA Grant Of Rolling Review Of Neutrolin New Drug Application
01:16pm, Monday, 03'rd Feb 2020CorMedix Inc. Announces FDA Grant of Rolling Review of Neutrolin® New Drug Application
01:15pm, Monday, 03'rd Feb 2020
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,
Investors Who Bought CorMedix (NYSEMKT:CRMD) Shares Five Years Ago Are Now Down 59%
11:58am, Monday, 03'rd Feb 2020
While it may not be enough for some shareholders, we think it is good to see the CorMedix, Inc. (NYSEMKT:CRMD) share...
